Video index

1. Call to order

3. Public comment and discussion on the July drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

4. Public comment and discussion on the October drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

2. Consideration of July 21, 2023, draft meeting minutes

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL

6. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

7. Executive work session

8. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

9. Review of action items for next meeting: January 26, 2024, 9:00 a.m.

Oct 12, 2023 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order

3. Public comment and discussion on the July drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

4. Public comment and discussion on the October drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

2. Consideration of July 21, 2023, draft meeting minutes

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL

6. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

7. Executive work session

8. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

9. Review of action items for next meeting: January 26, 2024, 9:00 a.m.

© 2003-2024 Swagit Productions, LLC